tradingkey.logo

Progyny Inc

PGNY

22.240USD

-0.270-1.20%
Market hours ETQuotes delayed by 15 min
1.91BMarket Cap
35.97P/E TTM

Progyny Inc

22.240

-0.270-1.20%
More Details of Progyny Inc Company
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Company Info
Ticker SymbolPGNY
Company nameProgyny Inc
IPO dateOct 25, 2019
CEOMr. Peter (Pete) Anevski
Number of employees675
Security typeOrdinary Share
Fiscal year-endOct 25
Address1359 Broadway
CityNEW YORK
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code10018
Phone12128883124
Websitehttps://www.progyny.com/
Ticker SymbolPGNY
IPO dateOct 25, 2019
CEOMr. Peter (Pete) Anevski
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
248.40K
-3.11%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
--
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+41.26%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+53.50%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+57.70%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
19.73K
+68.59%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
17.18K
-5.18%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
14.11K
-15.93%
Mr. Mark S. Livingston
Mr. Mark S. Livingston
Chief Financial Officer
Chief Financial Officer
9.18K
-21.48%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
248.40K
-3.11%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
--
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+41.26%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+53.50%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+57.70%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Fertility benefits services revenue
206.41M
63.70%
Pharmacy benefits services revenue
117.63M
36.30%
By RegionUSD
Name
Revenue
Proportion
United States
324.04M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Fertility benefits services revenue
206.41M
63.70%
Pharmacy benefits services revenue
117.63M
36.30%
Shareholding Stats
Updated: Wed, Aug 20
Updated: Wed, Aug 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.11%
The Vanguard Group, Inc.
11.46%
Seidenberg (Beth C)
6.22%
Kleiner, Perkins, Caufield & Byers
5.90%
Thrivent Asset Management, LLC
5.69%
Other
57.62%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.11%
The Vanguard Group, Inc.
11.46%
Seidenberg (Beth C)
6.22%
Kleiner, Perkins, Caufield & Byers
5.90%
Thrivent Asset Management, LLC
5.69%
Other
57.62%
Shareholder Types
Shareholders
Proportion
Investment Advisor
54.81%
Investment Advisor/Hedge Fund
29.65%
Individual Investor
7.58%
Hedge Fund
7.21%
Venture Capital
5.97%
Research Firm
4.33%
Pension Fund
1.60%
Bank and Trust
0.39%
Sovereign Wealth Fund
0.13%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
750
92.53M
107.94%
-27.39M
2025Q1
761
91.24M
106.44%
-29.72M
2024Q4
736
97.21M
113.81%
-18.60M
2024Q3
721
97.59M
108.87%
-13.76M
2024Q2
700
102.42M
113.70%
-10.92M
2024Q1
684
101.40M
106.22%
-3.55M
2023Q4
667
98.10M
102.55%
-7.56M
2023Q3
653
97.93M
102.95%
-1.75M
2023Q2
657
95.12M
99.98%
-10.18M
2023Q1
644
96.30M
102.13%
-5.85M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
11.02M
12.86%
-941.22K
-7.87%
Mar 31, 2025
The Vanguard Group, Inc.
8.60M
10.03%
-74.17K
-0.86%
Mar 31, 2025
Seidenberg (Beth C)
5.35M
6.24%
+7.21K
+0.13%
May 23, 2024
Kleiner, Perkins, Caufield & Byers
5.07M
5.92%
--
--
Mar 28, 2025
Thrivent Asset Management, LLC
5.35M
6.24%
+5.29M
+9244.37%
Mar 31, 2025
Fidelity Management & Research Company LLC
2.87M
3.35%
+2.74M
+2093.50%
Mar 31, 2025
State Street Global Advisors (US)
2.91M
3.4%
-223.01K
-7.11%
Mar 31, 2025
ArrowMark Colorado Holdings, LLC
2.21M
2.58%
+2.21M
--
Mar 31, 2025
Fred Alger Management, LLC
1.27M
1.48%
-381.30K
-23.15%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
iShares Russell 2000 ETF
0%
Vanguard S&P Mid-Cap 400 Index Fund
0%
iShares Core S&P Small-Cap ETF
0%
SPDR S&P 600 Small Cap Growth ETF
0%
Invesco S&P SmallCap Health Care ETF
0%
WisdomTree US MidCap Fund
0%
Invesco S&P SmallCap 600 Pure Growth ETF
0%
Ultra Mid Cap 400 Proshares
0%
Pacer US Small Cap Cash Cows ETF
0%
SPDR S&P 600 Small Cap Value ETF
0%
View more
iShares Russell 2000 ETF
Proportion0%
Vanguard S&P Mid-Cap 400 Index Fund
Proportion0%
iShares Core S&P Small-Cap ETF
Proportion0%
SPDR S&P 600 Small Cap Growth ETF
Proportion0%
Invesco S&P SmallCap Health Care ETF
Proportion0%
WisdomTree US MidCap Fund
Proportion0%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0%
Ultra Mid Cap 400 Proshares
Proportion0%
Pacer US Small Cap Cash Cows ETF
Proportion0%
SPDR S&P 600 Small Cap Value ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI